Healthcare-Acquired Infection: Devices, Pharmaceuticals, and Environmental Products

Report Code: HLC092A

Publish Date: Aug 2011

Publisher: BCC Publishing

Category: Health Maintenance

Customize This Report

Single User License: $2750

Member Price: FREE

Use code SUMMER at checkout for 50% OFF

Explore Our Services

Already a member? Login to access this report free.

Report Highlights

The global market for healthcare-acquired infection treatments were nearly $16 billion in year 2010. This market is estimated to be around $18.3 billion in the year 2011 and is forecasted to reach $25.6 billion by 2016 at a CAGR of 7.0% for five year period.

STUDY GOALS AND OBJECTIVES

Healthcare-acquired infections are viral, bacterial, or fungal infections that patients acquire after they are admitted to a healthcare facility.  Patients can acquire these infections from routine care; surgery; or as a complication from the use of medical devices such as ventilators, catheters, and intravenous lines. 

The Centers for Disease Control (CDC) estimates that 2 million HAIs occur annually in the U.S.  This leads to 100,000 deaths and costs an additional $36 billion to $45 billion in direct medical costs annually. 

This report is designed to investigate the global HAI market by treatment area and by treatment type, with supporting tables and figures to illustrate projected growth.  The report will include the U.S., Europe, Japan, and other countries such as China. 

This report offers forecasts of the markets for devices, pharmaceuticals, and therapies by treatment segment and treatment type from 2011 through 2016, including supporting analyses for projections.

This report is a valuable tool for anyone assessing the HAI market and attempting to devise a strategy to successfully compete in this market.  It provides background on the structure of the HAI market and the chief challenges and opportunities it faces.  It offers the information needed to understand the current market and to address the emerging one. 

This is an invaluable tool for business planners; acquisition specialists; licensing strategists; product managers; market research analysts; investing consultants; and others interested in the HAI market, its products, its participants, and its future.

ANALYST CREDENTIALS

Peggy S. Lehr is the BCC Research analyst of this report.  Ms. Lehr holds a BS in Journalism from the University of Colorado, Boulder and an MS in Communication from the University of Denver.  Ms. Lehr has worked in the publishing industry with both for-profit and not-for-profit organizations.  She specializes in marketing reports on the medical industry. 

Need a custom data table, graph, region, segment, companies or complete report? CUSTOMIZE NOW
Let us assist you! Our analysts are ready to tailor this report to your specific need. Talk to Our Analyst

Table of Contents

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
Title/Chapter NamePagesMember Price
Full Report: Healthcare-Acquired Infection: Devices, Pharmaceuticals, and Environmental Products203Free
Chapter- 1: INTRODUCTION3Free
Chapter- 2: SUMMARY 3Free
Chapter- 3: OVERVIEW30Free
Chapter- 4: GLOBAL HEALTHCARE-ACQUIRED INFECTION MARKET17Free
Chapter- 5: HAI PHARMACEUTICAL MARKET18Free
Chapter- 6: HAI ENVIRONMENTAL TREATMENT MARKET18Free
Chapter- 7: HAI MEDICAL DEVICES: CATHETERS, PATIENT VENTILATION SYSTEMS, AND IN-LINE STERILIZATION FILTERS17Free
Chapter- 8: REGULATIONS AND PATENTS36Free
Chapter- 9: CURRENT RESEARCH AND EMERGING THERAPIES9Free
Chapter- 10: C. CRAMER & CO. GMBH52Free

Related Reports

Antiseptics and Disinfectants

Published - Jul 2011 | Publisher - Shalini Shahani Dewan | Code - CHM052B

The global market for antiseptics and disinfectants in 2009 was at about $3.4 billion, and with a 12% increase, sales reached about $3.8 billion in 2010. The market is expected to rise at a compound annual growth rate (CAGR) of 11.1% and reach $7.1 billion by 2016.

Microbial Products: Technologies, Applications and Global Markets

Published - Apr 2011 | Publisher - Andrew McWilliams | Code - BIO086A

The total global market for microbes and microbial products was worth more than $144 billion in 2010.  The 2011 market is projected to exceed $156 billion, and, by 2016, $259 billion, reflecting a 10.7% projected compound annual growth rate (CAGR) between 2011 and 2016.

The Global Market for AIDS/HIV Testing and Treatment

Published - Mar 2011 | Publisher - Paul Evers | Code - PHM058A

The global HIV/AIDS market, including branded products and generics, was valued at $11.3 billion in 2010. This market is expected to reach $11.8 billion in 2011 and increase at a 4.6% compound annual growth rate (CAGR) over the 2011-2016 forecast period to reach $14.1 billion in 2016.

Vaccine Technologies and Global Markets

Published - Jan 2011 | Publisher - Shalini Shahani Dewan | Code - PHM014D

Global sales of human and animal vaccines reached approximately $25.2 billion in 2009. The market is expected to rise at a compound annual growth rate (CAGR) of 17.9% to reach $64.2 billion by 2015.

Recent Reports

Wearable Medical Devices: Technologies and Global Markets

Published - Aug 2024 | Publisher - BCC Publishing | Code - HLC192D

The global market for wearable medical devices was valued at $35.6 billion in 2023. This market is estimated to grow from $45.0 billion in 2024 to $151.8 billion by the end of 2029, at a compound annual growth rate (CAGR) of 27.5% from 2024 through 2029.

Radiotherapy, Radiopharmaceuticals and Nuclear Medicine: Global Markets

Published - Aug 2024 | Publisher - BCC Publishing | Code - HLC176E

The global market for radiation therapy products and radiopharmaceuticals is expected to grow from $17.5 billion in 2024 and is projected to reach $31.3 billion by the end of 2029, at a compound annual growth rate (CAGR) of 12.3% during the forecast period of 2024 to 2029.

Routine Health Screening Market

Published - Jul 2024 | Publisher - BCC Publishing | Code - HLC299A

The global market for routine health screening is expected to grow from $59.7 billion in 2024 and is projected to reach $82.9 billion by the end of 2029, at a compound annual growth rate (CAGR) of 6.8% during the forecast period of 2024 to 2029.

Elder Care Services and Assistive Devices: Global Markets

Published - Jul 2024 | Publisher - BCC Publishing | Code - HLC062E

The global market for elder care services and assistive devices is expected to grow from $868.2 billion in 2024 and is projected to reach $1.1 trillion by the end of 2029, at a compound annual growth rate (CAGR) of 5.8% during the forecast period of 2024 to 2029.

Direct-to-Consumer Testing Industry: Global Markets

Published - Jun 2024 | Publisher - BCC Publishing | Code - HLC269B

The global market for direct-to-consumer (DTC) testing is estimated to increase from $1.6 billion in 2023 to reach $3.2 billion by 2029, at a compound annual growth rate (CAGR) of 12.5% from 2024 through 2029.

Top Trending Reports

Sensors: Technologies and Global Markets

Published - Jun 2024 | Publisher - BCC Publishing | Code - IAS006P

The global market for sensors is estimated to increase from $179.7 billion in 2023 to reach $300.5 billion by 2029, at a compound annual growth rate (CAGR) of 8.9% from 2024 through 2029.

Hydrogen Storage: Materials, Technologies and Global Markets

Published - Jul 2024 | Publisher - BCC Publishing | Code - EGY146C

The global market for hydrogen storage materials and technologies is expected to grow from $5.3 billion in 2023 to $7.7 billion by the end of 2028, at a compound annual growth rate (CAGR) of 7.6% from 2023 through 2028.

Solid State Batteries: Global Markets

Published - Jul 2024 | Publisher - BCC Publishing | Code - FCB053B

The global market for solid state batteries is estimated to increase from $274.0 million in 2023 to reach $1.7 billion by 2029, at a compound annual growth rate (CAGR) of 36.7% from 2024 through 2029.

Global Market for Cell and Gene Therapy

Published - Apr 2024 | Publisher - BCC Publishing | Code - BIO225B

The global market for cell and gene therapy is expected to grow from $7.2 billion in 2023 and projected to reach $23.3 billion by the end of 2028, at a compound annual growth rate (CAGR) of 26.4% during the forecast period of 2023 to 2028. 

Life Science Tools and Reagents: Global Markets

Published - Jul 2024 | Publisher - BCC Publishing | Code - BIO083E

The global market for life science tools and reagents, including COVID-19 diagnostics was valued at $59.4 billion in 2023. This market is expected to grow from $53.2 billion in 2024 to reach $66.5 billion by the end of 2029, at a CAGR of 4.6% during the forecast period of 2024-2029.

Become A Member

BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.

Find Out More

Custom Consulting

BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.

Customize Now

Scorecard

The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.

Find Out More

Innovation Spotlight

Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.

Find Out More
Healthcare-Acquired Infection: Devices, Pharmaceuticals, and Environmental Products
Customize Report